Drugs / SHP639
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03131167 | May 2017 → May 2018 | ocular hypertension, open-angle glaucoma | Shire | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SHP639 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03131167 ↗ |
| Modality | Peptide | “Drug SHP639 is a 9-amino acid, synthetic, C-type natriuretic peptide (CNP) analog.” NCT03131167 ↗ |
| Route | Topical | “SHP639 Topical Ophthalmic Solution” NCT03131167 ↗ |